| ECT2 promotes lung adenocarcinoma progression through extracellular matrix dynamics and focal adhesion signaling Z Kosibaty, Y Murata, Y Minami, M Noguchi, N Sakamoto Cancer Science 112 (2), 703-714, 2021 | 23 | 2021 |
| Cytoplasmic expression of epithelial cell transforming sequence 2 in lung adenocarcinoma and its implications for malignant progression Z Kosibaty, Y Murata, Y Minami, T Dai, J Kano, R Matsuoka, N Nakano, ... Laboratory Investigation 99 (4), 551-567, 2019 | 9 | 2019 |
| Ras-related protein Rab-32 and thrombospondin 1 confer resistance to the EGFR tyrosine kinase inhibitor osimertinib by activating focal adhesion kinase in non-small cell lung … Z Kosibaty, OT Brustugun, IJ Zwicky Eide, G Tsakonas, O Grundberg, ... Cancers 14 (14), 3430, 2022 | 6 | 2022 |
| High expression of Ras‐specific guanine nucleotide‐releasing factor 2 (RasGRF2) in lung adenocarcinoma is associated with tumor invasion and poor prognosis T Nakagawa, YJ Kim, J Kano, Y Murata, Z Kosibaty, M Noguchi, ... Pathology International 71 (4), 255-260, 2021 | 6 | 2021 |
| Plasma RNA profiling unveils transcriptional signatures associated with resistance to osimertinib in EGFR T790M positive non-small cell lung cancer patients A Alexeyenko, OT Brustugun, IJZ Eide, R Gencheva, Z Kosibaty, Y Lai, ... Translational Lung Cancer Research 11 (10), 2064, 2022 | 3 | 2022 |
| Mapping chromatin state and transcriptional response in CIC-DUX4 undifferentiated round cell sarcoma NJ Thomas, C Luck, N Shlimon, RK Ponce, Z Kosibaty, RA Okimoto bioRxiv, 2023.10. 11.561932, 2023 | 2 | 2023 |
| What is the role of membrane-located epithelial cell transforming sequence 2 at the interphase of lung adenocarcinoma cells? Y Murata, A Yoshida, Y Minami, Z Kosibaty, D Matsubara, M Noguchi Pathology International, 2023 | | 2023 |
| P2. 13-03 Plasma Profiling Unveils Transcriptional Signatures Associated with Resistance to Osimertinib in Non-Small Cell Lung Cancer A Alexeyenko, OT Brustugun, IJZ Eide, R Gencheva, Z Kosibaty, Y Lai, ... Journal of Thoracic Oncology 17 (9), S156, 2022 | | 2022 |
| Ras-Related Protein Rab-32 and Thrombospondin 1 Confer Resistance to the EGFR Tyrosine Kinase Inhibitor Osimertinib by Activating Focal Adhesion Kinase in Non-Small Cell Lung … Z Kosibaty, OT Brustugun, IJ Zwicky Eide, G Tsakonas, O Grundberg, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | | 2022 |
| ECT2 promotes cancer progression through alterations of cell-extracellular matrix interaction ZM Kosibaty, M Noguchi CANCER SCIENCE 112, 340-340, 2021 | | 2021 |
| Exploring the function and regulation of epithelial cell transforming sequence 2 in lung adenocarcinoma cells Z Kosibaty 筑波大学, 2020 | | 2020 |
| 肺腺癌における ECT2 の役割 野口雅之 医学のあゆみ 271 (6), 609-610, 2019 | | 2019 |
| P2. 14-22 Loss of Ect2 Expression Impairs Cell-Matrix Adhesion and FAK/Src Signaling in Lung Adenocarcinoma Cells Z Kosibaty, Y Murata, Y Minami, M Noguchi Journal of Thoracic Oncology 14 (10), S837, 2019 | | 2019 |
| Cytoplasmic Mislocalization of ECT2 Protein Is Associated with Poor Prognosis in Lung Adenocarcinoma Z Kosibaty, Y Murata, Y Minami, S Sakashita, M Noguchi JOURNAL OF THORACIC ONCOLOGY 12 (11), S2125-S2126, 2017 | | 2017 |
| P2. 02-073 Cytoplasmic Mislocalization of ECT2 Protein Is Associated with Poor Prognosis in Lung Adenocarcinoma Z Kosibaty, Y Murata, Y Minami, S Sakashita, M Noguchi Journal of Thoracic Oncology 12 (11), S2126-S2127, 2017 | | 2017 |
| P2. 01-071 Biological Implication of Cytoplasmic ECT2 in Malignant Progression of Lung Adenocarcinoma M Noguchi, Y Minami, Z Kosibaty, Y Murata, S Sakashita Journal of Thoracic Oncology 12, S830-S831, 2017 | | 2017 |
| P2. 01-071 Biological Implication of Cytoplasmic ECT2 in Malignant Progression of Lung Adenocarcinoma: Topic: Marker for Prognosis Z Kosibaty, Y Murata, Y Minami, S Sakashita, M Noguchi Journal of Thoracic Oncology 12 (1), S830-S831, 2017 | | 2017 |
| Expression of Cytoplasmic ECT2 as a New Prognostic Marker for Early-Stage Lung Adenocarcinoma Y Murata, Z Kosibaty, Y Minami, M Noguchi JOURNAL OF THORACIC ONCOLOGY 10 (9), S717-S717, 2015 | | 2015 |
